Apricus Biosciences (APRI) And Its European Partners To Sponsor Symposium On Vitaros® At The European Association Of Urology (EAU) Congress, Stockholm
4/7/2014 9:00:59 AM
SAN DIEGO, April 7, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced that the Company, along with its European commercial partners, is sponsoring a symposium – "A New Paradigm in the Treatment of ED - The Topical Option" – during the European Association of Urology (EAU) Congress. Vitaros® is Apricus' novel topical on-demand treatment for erectile dysfunction ("ED"), approved in Canada and nine countries in Europe. The symposium will take place in the Stockholmsmassan Exhibition & Convention Center, Room K2, on Friday, April 11 at 4:15 pm DST.
Help employers find you! Check out all the jobs and post your resume.
comments powered by